CF PharmTech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	351.27	414.9	81.94	70.61	74.84	183.29
Short-Term Investments	-	2.99	4.1	5.5	5.56	-
Trading Asset Securities	148.22	238.34	266.06	330.85	236.39	201.44
Cash & Short-Term Investments	499.49	656.22	352.1	406.96	316.79	384.73
Cash Growth	-	86.37%	-13.48%	28.46%	-17.66%	-38.19%
Accounts Receivable	174.86	159.37	27.13	2.87	8.94	1.09
Other Receivables	-	6.79	8.52	1.9	-	0.02
Receivables	174.86	166.15	35.65	4.77	8.94	1.6
Inventory	50.87	36.7	47.18	36.1	28.29	19.85
Restricted Cash	4.72	7.63	5.12	19.17	114.94	-
Other Current Assets	42.71	23.46	22.16	28.05	15.31	54.2
Total Current Assets	772.65	890.16	462.22	495.04	484.26	460.37
Property, Plant & Equipment	575.7	575.23	562.3	430.45	328.46	276.13
Long-Term Investments	32.5	3.7	1.83	1.9	-	105.76
Other Intangible Assets	154.5	21.65	33.22	44.92	52.15	32.58
Long-Term Deferred Tax Assets	117.01	110.77	94.87	92.97	83.69	62.47
Long-Term Deferred Charges	-	133.23	88.73	50.02	23.37	48.58
Other Long-Term Assets	85.16	41.51	15.81	19.85	43.27	6.92
Total Assets	1,738	1,776	1,259	1,135	1,015	992.97

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	22.68	21.38	20.59	27.21	13.12	13.83
Accrued Expenses	-	42.22	116.95	72.69	57.75	22.98
Short-Term Debt	-	10.01	15.01	-	-	-
Current Portion of Long-Term Debt	103.21	34.51	3.45	0.82	-	-
Current Portion of Leases	1.73	1.56	2.43	1.9	1.26	-
Current Income Taxes Payable	-	6.45	4.12	2.41	5.83	0.46
Current Unearned Revenue	-	10.82	6.46	35.35	21.8	11.61
Other Current Liabilities	113.13	67.01	76.59	31.09	37.44	24.81
Total Current Liabilities	240.76	193.96	245.61	171.47	137.19	73.69
Long-Term Debt	106.52	97.79	55.35	19.2	-	-
Long-Term Leases	0.87	1.69	2.85	-	0.24	1.44
Long-Term Unearned Revenue	47.3	14.49	15.94	34.46	15.86	1.28
Other Long-Term Liabilities	-	-	-	-	-	21.8
Total Liabilities	395.44	307.93	319.74	225.12	153.29	98.21

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	411.98	411.98	370.78	370.78	370.78	370.78
Additional Paid-In Capital	-	-	-	-	-	1,333
Retained Earnings	-	-802.41	-804.9	-825.99	-857.71	-808.31
Treasury Stock	-120.49	-2.09	-	-	-	-
Comprehensive Income & Other	1,051	1,861	1,373	1,365	1,349	-0.25
Shareholders' Equity	1,342	1,468	939.28	910.02	861.93	894.76
Total Liabilities & Equity	1,738	1,776	1,259	1,135	1,015	992.97

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	212.33	145.56	79.1	21.91	1.5	1.44
Net Cash (Debt)	287.17	510.66	273.01	385.05	315.28	383.29
Net Cash Growth	-	87.05%	-29.10%	22.13%	-17.74%	-38.42%
Net Cash Per Share	0.72	1.35	0.74	1.04	0.85	-
Filing Date Shares Outstanding	406.36	411.91	370.78	370.78	370.78	-
Total Common Shares Outstanding	406.36	411.91	370.78	370.78	370.78	-
Working Capital	531.89	696.2	216.61	323.58	347.08	386.68
Book Value Per Share	3.30	3.56	2.53	2.45	2.32	-
Tangible Book Value	1,188	1,447	906.06	865.11	809.78	862.17
Tangible Book Value Per Share	2.92	3.51	2.44	2.33	2.18	-
Buildings	-	394.32	236.47	167.34	154.04	106.64
Machinery	-	323.58	287.25	249.45	175.92	151.25
Construction In Progress	-	56.69	180.94	117.61	71.29	90.02
Leasehold Improvements	-	17.35	17.35	14.23	7.68	-